Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2013
09/17/2013CA2550983C Enhanced absorption of modified release dosage forms
09/17/2013CA2549916C Transdermal delivery system of hormones without penetration enhancers
09/17/2013CA2545006C Biosensors for detecting macromolecules and other analytes
09/17/2013CA2536764C .alpha.-aminoamide derivatives useful as anti-inflammatory agents
09/17/2013CA2531980C Imide derivatives as therapeutic agents for senile dementia
09/17/2013CA2529318C Methods of inhibiting vascular permeability and apoptosis
09/17/2013CA2521883C Indene derivatives as pharmaceutical agents
09/17/2013CA2515890C Novel insertion sites in pox vectors
09/17/2013CA2498644C Anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (no) production
09/17/2013CA2451738C Methods for increasing in vivo efficacy of oligonucleotides and inhibiting inflammation in mammals using 2-amino-2'-deoxyadenosine
09/17/2013CA2445381C Phosphorous antimicrobial compounds and methods for their use
09/17/2013CA2423093C Improved system for regulation of transgene expression
09/17/2013CA2285701C .beta.-catenin, tcf-4, and apc interact to prevent cancer
09/12/2013WO2013134774A1 Modulation of breast cancer growth by modulation of xbp1 activity
09/12/2013WO2013134667A1 Modulating afferent signals to treat medical conditions
09/12/2013WO2013134660A1 4 -hydroxy- isoquinoline compounds as hif hydroxylase inhibitors
09/12/2013WO2013134632A2 Treatment for high cholesterol
09/12/2013WO2013134626A1 Prevention and treatment of respiratory infection with peroxisome proliferator activator receptor delta agonist
09/12/2013WO2013134562A1 Triazolone compounds and uses thereof
09/12/2013WO2013134558A1 Cancer treatment targeting non-coding rna overexpression
09/12/2013WO2013134546A1 Methods and materials for treating cancer
09/12/2013WO2013134530A1 High concentration alpha-glucosidase compositions for the treatment of pompe disease
09/12/2013WO2013134527A1 Synthesis of polycyclic alkaloids and their use as tgr5 agonists
09/12/2013WO2013134518A1 Sulfamide sodium channel inhibitors
09/12/2013WO2013134482A1 Methods for enhancing, improving, or increasing fertility or reproductive function
09/12/2013WO2013134467A1 Selective histone deactylase 6 inhibitors
09/12/2013WO2013134415A1 Mannose derivatives for treating bacterial infections
09/12/2013WO2013134403A1 Method of treating neurodegenerative diseases with microrna regulators
09/12/2013WO2013134398A1 Procaspase combination therapy for glioblastoma
09/12/2013WO2013134376A1 Positive allosteric modulators for melanocortin receptors
09/12/2013WO2013134371A1 Methods and compounds to be used in the treatment of neurodegenerative diseases
09/12/2013WO2013134362A1 Improved stability of hydromorphone hydrochloride solutions
09/12/2013WO2013134353A1 Fused bicyclic 2,4-diaminopyrimidine derivative as a dual alk and fak inhibitor
09/12/2013WO2013134348A1 Controlled-release solid dosage forms of mesalamine
09/12/2013WO2013134336A2 Inhibition of adaptor associated kinase 1 for the treatment of pain
09/12/2013WO2013134311A1 Steroid hormone and cholesterol pathways as one unified homestatic system
09/12/2013WO2013134293A1 Vaccine formulation
09/12/2013WO2013134288A1 Polymorphic forms of (s)-2-(1-(9h-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3h)-one
09/12/2013WO2013134252A1 2-amino, 6 - phenyl substituted pyrido [2, 3 - d] pyrimidine derivatives useful as raf kinase inhibitors
09/12/2013WO2013134243A1 2-amino, 6-phenyl substituted pyrido [2, 3 - d] pyrimidine derivatives useful as raf kinase inhibitors
09/12/2013WO2013134228A1 PYRAZOLO[1,5-a]PYRIMIDINE-BASED COMPOUNDS, COMPOSITIONS COMPRISING THEM, AND METHODS OF THEIR USE
09/12/2013WO2013134226A1 Benzodioxanes for inhibiting leukotriene production
09/12/2013WO2013134219A1 Imidazo [1, 2 - b] pyridazine - based compounds, compositions comprising them, and uses thereof
09/12/2013WO2013134209A1 Metabolic downregulation for cell survival
09/12/2013WO2013134142A1 Inhibitors of human immunodeficiency virus replication
09/12/2013WO2013134135A1 Small-molecule inhibitors of dengue and west nile virus proteases
09/12/2013WO2013134113A1 Fused pyrimidines as inhibitors of immunodeficiency virus replication
09/12/2013WO2013134085A1 Inhibitors of beta-secretase
09/12/2013WO2013134080A2 Improved method and compound for treatment of menopausal symptoms
09/12/2013WO2013134079A1 Oxazolidinone compounds and derivatives thereof
09/12/2013WO2013134061A1 Phenicol antibacterials
09/12/2013WO2013134036A1 Aryl ether-base kinase inhibitors
09/12/2013WO2013134012A1 Preparation and use of bicyclic himbacine derivatives as par-receptor antagonists
09/12/2013WO2013133980A1 Nitroxy derivatives of soft steroids
09/12/2013WO2013133927A1 Pharmaceutical compositions of 2'-c-methyl-guanosine, 5'-[2-[(3-hydroxy-2,2-dimethyl-1-oxopropyl)thio]ethyl n-(phenylmethyl)phosphoramidate]
09/12/2013WO2013133783A1 Composition and methods to enhance anti-oxidation, gut flora and immunity in pets
09/12/2013WO2013133781A1 The use of methyl-silicic acid for the treatment of parodontium tissues
09/12/2013WO2013133723A1 Synthesis of elemicin and topical analgesic compositions
09/12/2013WO2013133713A1 Animal feed composition containing encapsulated glucono delta-lactone
09/12/2013WO2013133711A1 Liquid nutritional composition comprising free amino acids
09/12/2013WO2013133691A1 Liquid nutritional composition comprising free amino acids
09/12/2013WO2013133647A1 Stable liquid pharmaceutical composition containing piroxicam or its pharmaceutically acceptable salt and hyaluronic acid or its pharmaceutically acceptable salt and the manufacturing method thereof
09/12/2013WO2013133620A1 Pharmaceutical composition comprising clopidogrel and aspirin and process for preparing the same
09/12/2013WO2013133556A1 Novel triazolo pyridazine derivative and use therefor
09/12/2013WO2013133450A1 Pharmaceutical composition for treating cancer
09/12/2013WO2013133442A1 Food or beverage that allows high degree of absorption of water
09/12/2013WO2013133408A1 Liquid medicine for internal use
09/12/2013WO2013133399A1 Dna-damaging agent
09/12/2013WO2013133393A1 Single-stranded nucleic acid molecule for inhibiting vegf gene expression
09/12/2013WO2013133390A1 Anti-nephropathic drug
09/12/2013WO2013133388A1 Adhesive patch
09/12/2013WO2013133387A1 Adhesive patch
09/12/2013WO2013133367A1 Novel triazine derivative
09/12/2013WO2013133325A1 Tricyclic compound
09/12/2013WO2013133221A1 micro-RNA INHIBITOR
09/12/2013WO2013132873A1 Promoter for expression of hyaluronic acid synthase gene
09/12/2013WO2013132668A1 Composition comprising imidazole peptide and quercetin glycoside
09/12/2013WO2013132526A1 Use of sphingosine-1 -phosphate receptors modulators for improving vaccine immunization
09/12/2013WO2013132512A1 "pharmaceutical composition of raloxifene hydrochloride"
09/12/2013WO2013132509A1 Novel compounds for the treatment of dyslipidemia and related diseases
09/12/2013WO2013132490A1 Compositions and methods of treatment of status epilepticus
09/12/2013WO2013132489A1 Nucleoside 5'-phosphorothioate analogues and uses thereof
09/12/2013WO2013132485A1 Polymers having therapeutically active agents conjugated thereto, processes of preparing same and uses thereof
09/12/2013WO2013132444A1 Fulvic acid and antibiotic combination for the inhibition or treatment of multi-drug resistant bacteria
09/12/2013WO2013132380A1 Thiazole derivatives as alpha 7 nachr modulators
09/12/2013WO2013132376A1 Macrocyclic derivatives for the treatment of proliferative diseases
09/12/2013WO2013132334A1 Antimicrobial compostion containing lauric acid and method for their production
09/12/2013WO2013132322A1 Gynecologic composition to treat vulvar vestibulitis
09/12/2013WO2013132314A1 Tenofovir phosphate, processes for the preparation and pharmaceutical composition thereof
09/12/2013WO2013132270A1 Phosphoinositide 3-kinase inhibitors
09/12/2013WO2013132263A1 Picropodophyllin derivatives for use in therapy
09/12/2013WO2013132253A1 3-aryl-5-substituted-isoquinolin-1-one compounds and their therapeutic use
09/12/2013WO2013132208A1 Pharmaceutical antiretroviral combinations comprising lamivudine, festinavir and nevirapine
09/12/2013WO2013132124A1 Sulforaphane-derived compounds, production method thereof and the medical, food and cosmetic use of same
09/12/2013WO2013132092A1 Use of monounsaturated fatty acid compounds for controlling the body weight of a dog or a cat
09/12/2013WO2013131985A1 Immunologically useful arginine salts
09/12/2013WO2013131983A1 Adjuvanted formulations of streptococcus pneumoniae antigens
09/12/2013WO2013131967A1 Pharmaceutical compositions comprising metformin and a dpp -4 inhibitor or a sglt-2 inhibitor
09/12/2013WO2013131935A1 Pyridinone and pyridazinone derivatives as mch - receptor modulators
09/12/2013WO2013131931A1 Aminomethylene pyrazolones with therapeutic activity
1 ... 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 ... 7860